A brief intervention program makes it easier for children as young as 5 years old to stay still during MRI exams so they can be scanned without sedation.
A brief, targeted intervention program makes it easier for children as young as 5 years old to stay still during MRI exams - allowing them to be scanned without sedation, according to a study published online in Pediatric Radiology.
Researchers at St. Jude Children’s Research Hospital followed 71 children, aged 5 to 12, who had sickle cell disease and had to undergo several MRIs, often of the brain or liver. Thirty-three children were taught about what the MRI did and what they could expect while being scanned. They were then given jobs to focus on during the scans, as well as coping strategies.
“Some patients chose to listen to music or to squeeze a ball to help them remember not to move,” said Katherine Cejda, a Child Life specialist at the hospital and the study’s first author. The children could also choose to have a parent or adult in the room with them during the exam, or they could even watch a movie.
Researchers found that the children who participated in this program were eight times more likely to complete the scans without needing to be sedated than those not exposed to the program. Ninety-one percent of the intervention group underwent MRIs without sedation, compared with 71 percent who did not participate in the program before an MRI without sedation.
The program, which is now offered to all children at St. Jude, has been used to help children as young as 4 years old. Senior author Jane Hankins, MD, an associate member of the department of hematology, said, “This preparation program offers a real advantage to patients.”
New Literature Review Assesses Merits of Cardiac MRI After Survival of Sudden Cardiac Arrest
April 19th 2024While noting inconsistencies with the diagnostic yield of cardiac MRI in patients who survived sudden cardiac arrest, researchers cited unique advantages in characterizing ischemic cardiomyopathy (ICM) and facilitating alternate diagnoses.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
MRI-Based AI Model Shows Promise in Predicting Lymph Node Metastasis with Breast Cancer
April 15th 2024For the prediction of axillary lymph node metastasis in patients with breast cancer, an MRI-based, 4D convolutional neural network model demonstrated an AUC of 87 percent and sensitivity of 89 percent, according to new research.